Search

NEW YORK, NY -- The following information was released by Columbia University: A new study in mice by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a [...]

LOS ANGELES, CA -- The following information was released by UCLA Health System: A new precision medicine approach that combines genetic and functional profiling helps predict how glioblastoma will respond [...]

STANFORD, Calif. -- The following information was released by the Stanford University School of Medicine: CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that [...]

STANFORD, Calif. -- The following information was released by the Stanford University School of Medicine: By Erin Digitale Crystal Mackall, left, and Michelle Monje led a clinical trial of an [...]

SOMERVILLE: Aitia has issued the following press release: Aitia, a biotech company pioneering the use of causal AI and Digital Twins in drug discovery and development, is expanding its collaboration [...]

SOMERVILLE, Mass., Oct. 30, 2024 /PRNewswire/ -- Aitia, a biotech company pioneering the use of causal AI and Digital Twins in drug discovery and development, is expanding its collaboration with [...]

The FDA has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center. The supplemental designation applies to SurVaxM as [...]

Paris: NH TherAguix (NHT), a phase II clinical stage biotechnology company specializing in the development of novel nanomedicine solutions applicable to precision radiotherapy in oncology, today announced that its lead [...]

Byline: Andrew Gregory Health editor The NHS is to offer children with brain tumours in England a groundbreaking new targeted drug therapy to tackle the disease -- a development charities [...]

FOSTER CITY: Apollomics Inc., announces that its partner in China, Avistone Biotechnology Co. Ltd. (Avistone), received approval from the National Medical Products Administration of China for vebreltinib for the treatment [...]

BRISBANE: Day One Biopharmaceuticals, Inc. has received approval from the U.S. Food and Drug Administration (FDA) for OJEMDA (tovorafenib), a type II RAF inhibitor, for the treatment of patients 6 [...]

BERLIN: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), announces that the US [...]

Spotlight on Research Kushagra Gupta, Staff Reporter|March 26, 2015 Freda Li/Observer Senior Jessica Lin studied how a drug designed to lower blood cholesterol can reduce tumor growth. Just like many [...]

NEEDHAM: Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that the [...]

NEEDHAM: Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced that the [...]

PHILADELPHIA: NeuExcell Therapeutics has issued the following news release: On December 7, 2023, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation ('ODD') to NXL-004, an investigational AAV [...]

PHILADELPHIA, Dec. 18, 2023 /PRNewswire/ -- On December 7, 2023, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation ('ODD') to NXL-004, an investigational AAV gene therapy product [...]

Dublin: Research and Markets has issued the following news release: The 'Glioma Treatment Global Market Report 2023' report has been added to ResearchAndMarkets.com's offering. The global glioma treatment market is [...]

Novel cancer immunotherapy is being assessed in nationwide SURVIVE trial in adults with glioblastoma, and in studies for other applications in children and adults. The designation awarded to MimiVax Inc. [...]

CHICAGO: MAIA BIOTECHNOLOGY, INC. has issued the following news release: MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that its lead [...]

BERLIN: TME PHARMA N.V has issued the following news release: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by [...]

SAN DIEGO and SHANGHAI: ABM Therapeutics has issued the following news release: ABM Therapeutics is pleased to announce today that the U.S. Food and Drug Administration (FDA) has granted Fast [...]

SAN DIEGO and SHANGHAI, Sept. 26, 2023 /PRNewswire/ -- ABM Therapeutics is pleased to announce today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for [...]

Pune, India: The Insight Partners has issued the following news release: Glioma is a condition that covers a broad category of brain and spinal cord tumors that concern the glial [...]

BASKING RIDGE: Lisata Therapeutics, Inc. (Nasdaq: LSTA) ('Lisata' or the 'Company'), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today [...]

Phoenix, AZ: Ivy Brain Tumor Center has issued the following news release: In an effort to discover new treatments for brain tumors, such as glioblastoma, the Ivy Brain Tumor Center [...]

Wilmington: The global glioma treatment market size stood at US$ 4.39 Bn in 2021 and is likely to exceed US$ 7.51 Bn by 2031, expanding at a CAGR of 5.7% [...]

BOSTON, MA -- The following information was released by Dana-Farber Cancer Institute: Brain Tumors In the phase 3 INDIGO clinical trial co-led by Dana-Farber Cancer Institute, vorasidenib significantly prolonged progression [...]

PASADENA: LIXTE Biotechnology Holdings, Inc. has issued the following news release: LIXTE Biotechnology Holdings, Inc. ('LIXTE' or the 'Company') (Nasdaq: LIXT) today announced that a recently published article in the [...]

NEW YORK: IN8bio, Inc has issued the following news release: IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, announces FDA orphan drug designation [...]

COLD SPRING HARBOR, NY -- The following information was released by Cold Spring Harbor Laboratory (CSHL): The Takeaway Diffuse intrinsic pontine glioma (DIPG) is a deadly pediatric brain cancer with [...]

Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years Endpoints met in a prespecified interim analysis vorasidenib [...]

BOSTON, MA -- The following information was released by the Massachusetts General Hospital (MGH): Key Takeaways A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has shown [...]

BEDMINSTER, N.J., Feb. 13, 2023 /PRNewswire/ -- http://www.jubilanttx.com/., a clinical stage biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, today announced [...]

BOSTON: Tango Therapeutics, Inc. has issued the following news release: Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer [...]